A small trial found whey built more muscle than leucine-boosted collagen, though strength gains were similar. Collagen's benefit for tendons is still unproven.
Recap by typeshit. Full story at ZME Science.
Avi Roy points out that the largest test so far found no memory benefit from the drug in Ozempic, despite hopes raised by health record studies.
Balwinder Singh and Raman Baweja link GLP-1 use to less kidney replacement therapy in bipolar patients with CKD, and flag lithium toxicity cases.
Yale Medicine says 5% to 10% of people on GLP-1 weight loss drugs see little result, and points to diet as one factor that can blunt the effect.
24:26
A doctor's explainer sorting peptides into eight broad categories. An evergreen overview for anyone still learning the basics.
PEPT holds Eli Lilly, Novo Nordisk and smaller peptide makers. REX's Bill Birmingham ties the idea to both GLP-1 growth and the gray market peptide scene online.
WuXi AppTec lays out five peptide manufacturing trends for 2026, pointing to oral dosing as the reason makers need far more active ingredient. It's a company press release.
Loading…